$愛美醫療 (FOLD.US)$ Announces Topline Results from Phase 2b GAL...
$愛美醫療 (FOLD.US)$ Announces Topline Results from Phase 2b GALACTIC-1 Trial of GB0139 for the Treatment of Idiopathic Pulmonary Fibrosis.
GALACTIC-1 trial did not meet its primary endpoint.
Galecto to discontinue the development of GB0139.
GALACTIC-1 trial did not meet its primary endpoint.
Galecto to discontinue the development of GB0139.
免責聲明:社區由Moomoo Technologies Inc.提供,僅用於教育目的。
更多信息
評論
登錄發表評論